Department of General Surgery, University of Toledo, Toledo, Ohio.
Promedica, Jobst Vascular Institute, Toledo, Ohio.
J Vasc Surg Venous Lymphat Disord. 2021 Jul;9(4):1071-1076.e1. doi: 10.1016/j.jvsv.2020.12.085. Epub 2021 Feb 26.
Nonhealing leg ulcers are frequently associated with the saphenous vein reflux. Despite the success of endovascular ablations, there are patients who either fail to heal or develop recurrent ulcers. This systematic review aims to summarize the available evidence on how to treat these patients after successful elimination of superficial reflux.
A systematic review was performed following the PRISMA guidelines. The MEDLINE and Embase databases were searched for full text articles in English from 1946 to July 31, 2020. All articles that did not specifically mention the treatment of persistent venous ulcers or superficial venous reflux associated with healed or active venous ulcers were eliminated. The remaining abstracts were read for mention of either recurrent or persistent venous ulcers and, if mentioned, the full article was reviewed. All study designs were included. Study selection, data extraction and risk of bias assessment were performed by two independent reviewers.
Four eligible studies including a total of 161 patients (177 limbs) with C6 disease were included in the review after the screening of 546 identified articles. A total of 62 patients were treated for persistent or recurrent venous ulcers after treatment of superficial reflux. Treatments included four-layer compression dressings, repeat ablations of superficial veins, and endovenous ablation of incompetent perforator veins. Overall, successful healing was noted in 50% of patients undergoing repeat ablative procedures, 100% of patients treated solely with four-layer compression dressings, and 90% of patients treated with compression and successful ablation of incompetent perforator veins. Across all studies the presence of deep vein reflux was 31% (50 of 164 limbs), post-thrombotic (secondary) ulcers 13.7% (16 of 117), and proximal obstruction was present in a single patient. Superficial venous reflux was treated using endovenous ablation (either radiofrequency ablation or laser), foam sclerotherapy, and endovenous radiofrequency ablation with or without microphlebectomy procedures. The frequency of persistent ulcers after elimination of superficial reflux ranged from 2.3% at 2 years after the intervention to 21.1% at 1 year with follow-up ranging from 6 to 52 months.
Although further studies are warranted to improve the quality of evidence, it seems that additional ablative procedures to address incompetent perforating veins and persistent superficial reflux in combination with ongoing compression therapy is effective in healing persistent or recurrent venous ulcers after the elimination of superficial venous reflux.
不愈合的腿部溃疡常与隐静脉反流有关。尽管血管内消融术取得了成功,但仍有一些患者无法愈合或出现复发性溃疡。本系统评价旨在总结现有证据,探讨如何在成功消除浅表反流后治疗这些患者。
根据 PRISMA 指南进行系统评价。检索 1946 年至 2020 年 7 月 31 日 MEDLINE 和 Embase 数据库的英文全文文献。排除未专门提及治疗持续性静脉溃疡或与愈合或活动性静脉溃疡相关的浅表静脉反流的文章。阅读其余的摘要,以了解是否提到复发性或持续性静脉溃疡,如果提到,则回顾全文。所有研究设计均被纳入。由两名独立评审员进行研究选择、数据提取和偏倚风险评估。
经过对 546 篇已识别文章的筛选,共有 4 项符合条件的研究,共纳入 161 例(177 条肢体)C6 疾病患者纳入本综述。在治疗浅表反流后,共有 62 例患者接受持续性或复发性静脉溃疡治疗。治疗方法包括四层压缩敷料、重复消融浅表静脉和腔内消融功能不全穿通静脉。总的来说,接受重复消融治疗的患者中,50%的患者愈合成功,仅接受四层压缩敷料治疗的患者中,100%的患者愈合成功,接受压缩和功能不全穿通静脉成功消融治疗的患者中,90%的患者愈合成功。所有研究中,深静脉反流的存在率为 31%(164 条肢体中的 50 条),血栓后(继发性)溃疡为 13.7%(117 条肢体中的 16 条),单一肢体存在近端阻塞。浅表静脉反流采用静脉内消融(射频消融或激光)、泡沫硬化剂治疗、静脉内射频消融联合或不联合微静脉切除术治疗。消除浅表反流后持续性溃疡的发生率范围为干预后 2 年的 2.3%至 1 年的 21.1%,随访时间为 6 至 52 个月。
尽管需要进一步研究来提高证据质量,但似乎对功能不全穿通静脉和持续性浅表反流进行额外消融治疗,并结合持续的压缩治疗,对消除浅表静脉反流后治疗持续性或复发性静脉溃疡是有效的。